Susquehanna International Group, LLP Edwards Lifesciences Corp Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 168,774 shares of EW stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,774

Previous 172,728 2.29%

Holding current value

$11 Million

Previous $16.5 Million 5.55%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$84.3 - $94.31 $333,322 - $372,901	-3,954 Reduced 2.29%	168,774 $15.6 Million
Q1 2024 May 07, 2024	SELL	$72.54 - $95.56 $3 Million - $3.95 Million	-41,318 Reduced 19.3%	172,728 $16.5 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $4.43 Million - $5.59 Million	-71,839 Reduced 25.13%	214,046 $16.3 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.61 Million - $2.16 Million	23,177 Added 8.82%	285,885 $19.8 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $8.93 Million - $10.3 Million	-109,695 Reduced 29.46%	262,708 $24.8 Million
Q1 2023 May 16, 2023	BUY	$74.26 - $84.51 $8.64 Million - $9.83 Million	116,362 Added 45.45%	372,403 $30.8 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $6.52 Million - $8.35 Million	95,472 Added 59.46%	256,041 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $5.23 Million - $6.81 Million	63,474 Added 65.37%	160,569 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $11.3 Million - $16.8 Million	-131,000 Reduced 57.43%	97,095 $9.23 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $8.84 Million - $11.1 Million	86,726 Added 61.35%	228,095 $26.9 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.9 Million - $3.56 Million	27,275 Added 23.91%	141,369 $18.3 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $16.5 Million - $19.6 Million	-159,960 Reduced 58.37%	114,094 $12.9 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $10.7 Million - $13.4 Million	127,637 Added 87.17%	274,054 $28.4 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $5.63 Million - $6.49 Million	71,525 Added 95.5%	146,417 $12.2 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $4.92 Million - $6.26 Million	68,668 Added 1103.28%	74,892 $6.83 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $627,218 - $816,252	-9,335 Reduced 60.0%	6,224 $497,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $312,844 - $418,377	-5,437 Reduced 25.9%	15,559 $1.08 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $3.42 Million - $5.29 Million	-65,339 Reduced 75.68%	20,996 $3.96 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $6.07 Million - $6.95 Million	84,679 Added 5113.47%	86,335 $20.1 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1.24 Million - $1.53 Million	-20,219 Reduced 92.43%	1,656 $364,000
Q2 2019 Aug 16, 2019	BUY	$55.74 - $64.41 $826,122 - $954,620	14,821 Added 210.11%	21,875 $4.04 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $16,331 - $18,872	293 Added 4.33%	7,054 $1.3 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $32,996 - $44,130	-689 Reduced 9.25%	6,761 $1.29 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1.24 Million - $1.57 Million	-27,039 Reduced 78.4%	7,450 $1.3 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $1.34 Million - $1.62 Million	-31,483 Reduced 47.72%	34,489 $5.02 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $722,713 - $922,095	19,433 Added 41.76%	65,972 $9.2 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $1.02 Million - $1.19 Million	-30,232 Reduced 39.38%	46,539 $5.25 Million
Q3 2017 Nov 20, 2017	BUY	$36.29 - $38.83 $2.79 Million - $2.98 Million	76,771	76,771 $8.39 Million

Others Institutions Holding EW

# of Institutions

1,418

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Edwards Lifesciences Corp Transaction History